Healthcare IT Today November 24, 2021
Where are pharma companies investing their windfall profits? The companies are evolving in many ways, including stepping outside drug development to tryout digital treatments and using lessons from the COVID-19 pandemic to rethink production and clinical trials.
I spoke recently to Daniel Fallmann, founder and CEO of Mindbreeze, about what pharma companies are doing with their data mining and machine learning platform.
Surfacing hidden information
Mindbreeze’s service, Mindbreeze InSpire, slurps up pharma companies’ data and serves it up to knowledge workers, who are looking for patterns that can help them identify new relationships and ultimately derive clinical or business insights. For instance, some of Mindbreeze InSpire’s main users are reviewers of the companies’ drug submissions. These reviewers employ Mindbreeze InSpire...
Today's Sponsors
Today's Sponsor